NEVRO CORP

 NVROのチャート


 NVROの企業情報

symbol NVRO
会社名 Nevro Corp (NEVRO CORP)
分野(sector)   
産業(industry)   
業種 医療機器_医療用品_ディストリビュ―タ―   医療関連(Health Care)
概要 ネブロ(Nevro Corp)は医療機器の提供者である。同社は慢性疼痛患者の生活の質を改善する製品を提供することに重点を置く。同社は慢性疼痛の治療のための神経調節プラットフォームであるSenza脊髄電気刺激(SCS)システムを開発・商品化する。同社のHF10療法は慢性疼痛の治療のための神経調節溶液を送達するように設計される。HF10療法は患者が異常感覚を伴わずに持続的鎮痛軽減を達成することを可能にし、不快なショッキングまたは激しい感覚を避けることができる。HF10療法は解剖学的リードの配置に依存する。Senzaシステムは2ヘルツ(Hz)から10000 Hzまでの電気インパルスを生成する。  ネブロは、米国の医療機器メ―カ―。慢性疼痛の治療のための神経調節プラットフォ―ムを開発し、商品化。同社の製品「SENZA」システムは、HF10治療を提供する脊髄刺激(SCS)システムである。SENZAは、10kHzの波形刺激を出すHF10治療に加え、2Hzから10kHzの電気刺激が出るように設計。感覚異常を起こさずに痛みを軽減する。  Headquartered in Redwood City, California, Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. Nevro has developed and commercialized the Senza spinal cord stimulation (SCS) system, an evidence-based, non-pharmacologic neuromodulation platform for the treatment of chronic pain. HF10 therapy has demonstrated the ability to reduce or eliminate opioids in =65% of patients across six peer-reviewed clinical studies. The Senza® System, Senza II™ System, and the Senza® Omnia™ System are the only SCS systems that deliver Nevro's proprietary HF10® therapy. Senza, Senza II, Senza Omnia, HF10, Nevro and the Nevro logo are trademarks of Nevro Corp.
本社所在地 1800 Bridge Parkway Redwood City CA 94065 USA
代表者氏名 D.Keith Grossman
代表者役職名 President Chief Executive Officer Director
電話番号 +1 650-251-0005
設立年月日 38777
市場名 NYSE(ニューヨーク証券取引所)
ipoyear
従業員数 804人
url www.nevro.com
nasdaq_url
adr_tso
EBITDA (百万ドル) -37.85600
終値(lastsale)
時価総額(marketcap)
時価総額 (百万ドル) 1949.35500
売上高 (百万ドル) 387.28900
企業価値(EV) (百万ドル) 1837.20200
当期純利益 (百万ドル) -49.20500
決算概要 BRIEF: For the fiscal year ended 31 December 2018 Nevro Corp revenues increased 19% to $387.3M. Net loss increased 34% to $49.2M. Revenues reflect United States segment increase of 22% to $321.8M. Higher net loss reflects Selling/General/Admin. Expense - Balanci increase of 19% to $238.5M (expense) Research and Development Expense - Bal increase of 29% to $42.6M (expense).

 NVROのテクニカル分析


 NVROのニュース

   Spinal Cord Stimulation Devices Market Outlook, Industry Size, Market Share, Forecast Till 2028 | Boston, Scientific and corporation, Medtronic plc, Nevro corp  2021/03/04 12:43:28 OpenPR
Allied Market Research (USA, Oregon, Portland) Published Latest Report titled, ‘Spinal Cord Stimulation Devices Market: Global Opportunity Analysis and Industry Forecast 2020-2027’. The Spinal Cord Stimulation Devices Market is expected to witness growth in upcoming years due to factors such as
   Nevro (NYSE:NVRO) Announces Quarterly Earnings Results  2021/02/26 18:24:41 Transcript Daily
Nevro (NYSE:NVRO) announced its quarterly earnings results on Tuesday. The medical equipment provider reported ($0.21) earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.33) by $0.12, MarketWatch Earnings reports. Nevro had a negative return on equity of 30.25% and a negative net margin of 24.46%. Shares of Nevro stock […]
   Nevro Reports Fourth Quarter and Full Year 2020 Financial Results  2021/02/24 21:05:00 PR Newswire
REDWOOD CITY, Calif., Feb. 24, 2021 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today reported its financial results for the fourth quarter and full year ended December…
   Nevro to Present at Citi's 2021 Healthcare Services, Medtech, Tools, & HCIT Virtual Conference  2021/02/01 12:00:00 PR Newswire
REDWOOD CITY, Calif., Feb. 1, 2021 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that D. Keith Grossman, Nevro's Chairman, CEO and President, will present…
   Nevro to Report Fourth Quarter and Full-Year 2020 Financial Results  2021/01/27 12:00:00 PR Newswire
REDWOOD CITY, Calif., Jan. 27, 2021 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that the company will report its financial results for the fourth quarter…
   Spinal Cord Stimulation Devices Market Outlook, Industry Size, Market Share, Forecast Till 2028 | Boston, Scientific and corporation, Medtronic plc, Nevro corp  2021/03/04 12:43:28 OpenPR
Allied Market Research (USA, Oregon, Portland) Published Latest Report titled, ‘Spinal Cord Stimulation Devices Market: Global Opportunity Analysis and Industry Forecast 2020-2027’. The Spinal Cord Stimulation Devices Market is expected to witness growth in upcoming years due to factors such as
   Nevro (NYSE:NVRO) Announces Quarterly Earnings Results  2021/02/26 18:24:41 Transcript Daily
Nevro (NYSE:NVRO) announced its quarterly earnings results on Tuesday. The medical equipment provider reported ($0.21) earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.33) by $0.12, MarketWatch Earnings reports. Nevro had a negative return on equity of 30.25% and a negative net margin of 24.46%. Shares of Nevro stock […]
   Nevro Reports Fourth Quarter and Full Year 2020 Financial Results  2021/02/24 21:05:00 PR Newswire
REDWOOD CITY, Calif., Feb. 24, 2021 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today reported its financial results for the fourth quarter and full year ended December…
   Nevro to Present at Citi's 2021 Healthcare Services, Medtech, Tools, & HCIT Virtual Conference  2021/02/01 12:00:00 PR Newswire
REDWOOD CITY, Calif., Feb. 1, 2021 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that D. Keith Grossman, Nevro's Chairman, CEO and President, will present…
   Nevro to Report Fourth Quarter and Full-Year 2020 Financial Results  2021/01/27 12:00:00 PR Newswire
REDWOOD CITY, Calif., Jan. 27, 2021 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that the company will report its financial results for the fourth quarter…
   Spinal Cord Stimulation Devices Market Outlook, Industry Size, Market Share, Forecast Till 2028 | Boston, Scientific and corporation, Medtronic plc, Nevro corp  2021/03/04 12:43:28 OpenPR
Allied Market Research (USA, Oregon, Portland) Published Latest Report titled, ‘Spinal Cord Stimulation Devices Market: Global Opportunity Analysis and Industry Forecast 2020-2027’. The Spinal Cord Stimulation Devices Market is expected to witness growth in upcoming years due to factors such as
   Nevro (NYSE:NVRO) Announces Quarterly Earnings Results  2021/02/26 18:24:41 Transcript Daily
Nevro (NYSE:NVRO) announced its quarterly earnings results on Tuesday. The medical equipment provider reported ($0.21) earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.33) by $0.12, MarketWatch Earnings reports. Nevro had a negative return on equity of 30.25% and a negative net margin of 24.46%. Shares of Nevro stock […]
   Nevro Reports Fourth Quarter and Full Year 2020 Financial Results  2021/02/24 21:05:00 PR Newswire
REDWOOD CITY, Calif., Feb. 24, 2021 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today reported its financial results for the fourth quarter and full year ended December…
   Nevro to Present at Citi's 2021 Healthcare Services, Medtech, Tools, & HCIT Virtual Conference  2021/02/01 12:00:00 PR Newswire
REDWOOD CITY, Calif., Feb. 1, 2021 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that D. Keith Grossman, Nevro's Chairman, CEO and President, will present…
   Nevro to Report Fourth Quarter and Full-Year 2020 Financial Results  2021/01/27 12:00:00 PR Newswire
REDWOOD CITY, Calif., Jan. 27, 2021 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that the company will report its financial results for the fourth quarter…

 関連キーワード  (医療機器_医療用品_ディストリビュ―タ― 米国株 NEVRO CORP NVRO )

医療で使われる機器のこと。レントゲン装置やからだの断面を画像化できるMRI(磁気共鳴画像)装置など高機能機器を含め数多くの種類がある。医療現場で使われるため、正確で精密である点などが求められる。医療機器への需要は着実に高まっており、電機メーカーなどからの進出も進んでいる。

 twitter  (公式ツイッターやCEOツイッターなど)